Diagnostic strategy in systemic inflammatory diseases

Acta Clinica Belgica

Volumn 62, Issue 1, 2007, Pages 26-35

  Knockaert, Daniël C ^a   Vanderschueren, S ^a   Blockmans, D E ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Diagnosis; Inflammation; Multisystem disease; Strategy; Systemic inflammatory diseases; Vasculitis

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; TUBERCULOSTATIC AGENT;

BIOPSY TECHNIQUE; CLINICAL ASSESSMENT; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; FOLLOW UP; HUMAN; LABORATORY TEST; LOW DRUG DOSE; PATTERN RECOGNITION; PHYSICAL EXAMINATION; RADIODIAGNOSIS; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 34047122170     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2007.005     Document Type: Review

References (45)

1. Knockaert DC. Systemic inflammatory diseases (SIDs), what's in a name Act Clin Belg 2007; 62(1): 21-5.
2. Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84: 223-43.
3. Watts RA, Lane S, Scott DG. What is known about the epidemiology of the vasculitides? Best Pract Res Clin Rheumatol 2005; 19: 191-207.
4. Cox CE, Davis-Allen A, Judson MA. Sarcoidosis. Med Clin N Am 2005 ; 89 : 817-28.
5. Narain S, Richards HB, Satoh M, et al. Diagnostic accuracy for lupus and other systemic autoimmune diseases in de community setting. Arch Intern Med 2004; 164: 2435-41.
6. Colglazier CL, Sutej PG. Laboratory testing in rheumatic diseases: a practical review. South Med J 2005; 98:185-91.
7. Kramers C, Adema GJ, Korte M, Deinum J. Familiaire hyperactiviteit van angiotensineconverterend enzyme (ACE). Ned Tijdschr Geneeskd 2003;147:507-10.
8. Burns JC, Glodé MP. Kawasaki syndrome. Lancet. 2004; 364: 533-44.
9. El-Shanti H, Majeed HA, El-Khateeb M. Familial Mediterranean Fever in Arabs. Lancet 2006; 367: 1016-24.
10. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classifications of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
11. Jenette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-92.
12. Rao JK, Allen NB, Pincus T. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med 1998; 129: 345-52.
13. Salvarani C, Hunder GG. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurrence in a population-based study. Arthritis Care & Research 2001; 45: 140-5.
14. Stojanov S, Kastner DL. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005; 17: 586-99.
15. Knockaert DC, Vanderschueren S, Blockmans D. Fever of unknown origin in adults: 40 years on. J Intern Med 2003: 253: 263-75.
16. Bush TM, Shlotzhauer TL, Grove W. Serum complements. Inappropriate use in patients with suspected rheumatic disease. Arch Intern Med 1993; 153: 2363-6.
17. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-63.
18. Slater CA, Davis RB, Shmerling RH Antinuclear antibody testing. Arch Intern Med 1996; 156: 1421-5.
19. Tan EM, Feltkamp TEW, Smolen JS, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis & Rheumatism 1997; 40: 1601-11.
20. Shmerling RH. Diagnostic tests for rheumatic disease: clinical utility revisited. South Med J 2005; 98: 704-11.
21. Wiik AS. Anti-nuclear autoantibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases. Scand J Rheumatol 2005;34: 260-8.
22. Shmerling RH. Autoantibodies in systemic lupus erythematosus - There before you know it. N Engl J Med 2003; 349: 1499-1500.
23. Dalakas MC; Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003; 362: 971-82.
24. Mandl LA, Solomon DH, Smith EL, Lew RA, Katz JN, Shmerling RH. Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis. Arch Intern Med 2002; 162: 1509-14.
25. Bosch X, Guilabert A, Font J. Antineutrophil cytoplasmic antibodies. Lancet 2006 ; 368 : 404-18.
26. Rao JK, Allen NB, Feussner JR, Weinberger M.A prospective study of antineutrophil cytoplasmic antibody (C-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis. Lancet 1995; 346: 926-31.
27. Merkel PA, Polisson RP, Chang YC, Skates SJ, Niles JL. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 1997; 126: 866-73.
28. Sablé-Fourtassou R, Cohen P, Mahr, et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005; 143: 632-8.
29. Guillevin L, Durand-Gasselin B, Cevallos R, et al. Microscopic polyangiitis, clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999; 42: 421-30.
30. Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JP. Meta-analysis: test performance of ultrasonography for giant cell arteritis. Ann Intern Med 2005; 142: 359-69.
31. Haroche J, Amoura Z, Dion E, et al. Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease. Medicine 2004; 83: 371-92.
32. Dahlberg Ph, Lockhart JM, Overholt EL. Diagnostic studies for systemic necrotizing vasculitis. Arch Intern Med 1989; 149: 161-5.
33. Desmet GD, Knockaert DC, Bobbaers HJ. Temporal arteritis: the silent presentation and delay in diagnosis. J Intern Med 1990; 227: 237-40.
34. Vanderschueren S, Depoot I, Knockaert DC, Verbeken EK, Zaman Z, Bobbaers H. Microscopic haematuria in giant cell arteritis. Clin Rheumatol 2002; 21: 373-7.
35. Blockmans D. Knockaert D, Bobbaers H. Giant cell arteritis can be associated with T4-Lymphocytic alveolitis. Clin Rheumatol 1999; 18: 330-3.
36. Seror R, Mahr A, Ramanoelina J, Pagnoux C, Cohen P, Guillevin L. Central nervous system involvement in Wegener granulomatois. Medicine 2006; 85: 54-65.
37. Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000; 108: 246-9.
38. Luqmani RA, Pathare S, Kwok-fai TL. How to diagnose and treat secondary forms of vasculitis. Best Pract Res Clin Rheumatol 2005; 19: 321-36.
39. Hamidou MA, Fradet G, Kadi AM, et al. Systemic vasculitis with lymphocytic temporal arteritis and toxocara canis infection. Arch Intern Med 2002; 162: 1521-4.
40. Shmerling RH. An 81-year-old woman with temporal arteritis. JAMA 2006; 295: 2525-34.
41. Nishino H, DeRemee RA, Rubino FA, Parisi JE. Wegener's granulomatosis associated with vasculitis of the temporal artery: report of five cases. Mayo Clin Proc 1993; 68: 115-21.
42. Fox R. Sjögren's syndrome. Lancet 2005; 366: 321-31.
43. Wolfert AL, Wright JE. Whipple's disease presenting as sarcoidosis and valvular heart disease. South Med J 1999; 92: 820-5.
44. Deeren D, Vanderschueren S, Ectors N, Blockmans D, Bobbaers H. Weight loss, joint pain and abdominal lymphadenopathy as signs of sarcoidosis, but also of Whipple's disease. Ned Tijdschr Geneeskd 2003; 147: 620-4.
45. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003; 362: 971-82.